Nasal spray for mild to moderate Alzheimer's disease
Part of Brain & nervous system clinical trials.
This trial tests a new nasal spray called NeuroEPO to see if it is safe and helps people with mild to moderate Alzheimer's disease. The study aims to improve memory and daily functioning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years of age or older.
- You have mild to moderate Alzheimer's disease (confirmed by a doctor).
- You have a caregiver who can help you during the study.
- You are not taking blood-thinning medications (like warfarin or heparin).
- You have no major nose or sinus problems (like frequent nosebleeds or recent surgery).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new treatment using tiny particles from stem cells (called exosomes) given as a nasal spray. It aims to see if it can help people with early-onset Alzheimer's disease, which starts before age 65.
This Phase 2 trial tests an oral medicine (EX039) to see if it can help people with mild Alzheimer’s disease. It focuses on slowing or improving thinking and memory problems over time.
This study tests a nasal spray combining two medicines to see if it can improve sleep and thinking in older adults with mild-to-moderate Alzheimer's-related memory problems. It may help if you have sleep issues along with memory loss.
This Phase 2 study tests whether sargramostim (a GM-CSF related medicine) is safe and can slow or improve Alzheimer’s symptoms. You might be a good fit if you have mild or moderate Alzheimer’s, positive amyloid testing, and can complete frequent visits with a close caregiver who knows you well.
This trial tests a new drug, NBI-1117567, for people with mild to moderate Alzheimer's disease who are already taking a standard Alzheimer's medication. The goal is to see if the new drug can help improve symptoms.
This trial tests an investigational injection for people in the early stages of Alzheimer's. It aims to see if the drug can safely slow down memory loss and brain changes.
Hear when a new Mild Alzheimer's Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.